Avalo Therapeutics Inc (AVTX)
11.54
-0.46
(-3.83%)
USD |
NASDAQ |
Apr 19, 16:00
11.54
0.00 (0.00%)
After-Hours: 18:44
Avalo Therapeutics Cash and Short Term Investments (Quarterly): 7.415M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.415M |
September 30, 2023 | 10.18M |
June 30, 2023 | 6.307M |
March 31, 2023 | 16.69M |
December 31, 2022 | 13.17M |
September 30, 2022 | 16.94M |
June 30, 2022 | 11.25M |
March 31, 2022 | 38.47M |
December 31, 2021 | 54.58M |
September 30, 2021 | 71.51M |
June 30, 2021 | 40.44M |
March 31, 2021 | 38.29M |
December 31, 2020 | 18.92M |
September 30, 2020 | 33.39M |
June 30, 2020 | 45.39M |
March 31, 2020 | 20.37M |
December 31, 2019 | 11.24M |
September 30, 2019 | 5.251M |
June 30, 2019 | 9.387M |
Date | Value |
---|---|
March 31, 2019 | 16.12M |
December 31, 2018 | 10.65M |
September 30, 2018 | 6.838M |
June 30, 2018 | 2.180M |
March 31, 2018 | 2.524M |
December 31, 2017 | 2.472M |
September 30, 2017 | 23.96M |
June 30, 2017 | 5.461M |
March 31, 2017 | 3.002M |
December 31, 2016 | 5.128M |
September 30, 2016 | 8.815M |
June 30, 2016 | 11.88M |
March 31, 2016 | 16.60M |
December 31, 2015 | 21.16M |
September 30, 2015 | 3.308M |
June 30, 2015 | 6.143M |
March 31, 2015 | 8.599M |
December 31, 2014 | 11.74M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.251M
Minimum
Sep 2019
71.51M
Maximum
Sep 2021
24.69M
Average
16.94M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Imunon Inc | 15.70M |
iBio Inc | 2.788M |
Kodiak Sciences Inc | 285.51M |
Petros Pharmaceuticals Inc | 13.34M |
Ocugen Inc | 39.46M |